NCT03511443

Evaluation of the Performance of a hsRDT Versus cRDT in Reactive Case Detection of Malaria Infections

Status unknown NA Last updated 27 April 2018

What this trial tests

NA trial testing hsRDT in Malaria Diagnosis in 1,980 participants. Status unknown.

Timeline

2 October 2017

Primary endpoint
28 June 2018

1 October 2018

Quick facts

Lead sponsor	University Research Co, LLC
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	1,980
Start date	2 October 2017
Primary completion	28 June 2018
Estimated completion	1 October 2018
Sites	1 location across Burma

Drugs / interventions tested

• hsRDT

Conditions studied

• Malaria Diagnosis — all drugs for Malaria Diagnosis →
• Malaria,Falciparum — all drugs for Malaria,Falciparum →

Sponsor

University Research Co, LLC

Who can join

5 and older, any sex, with Malaria Diagnosis or Malaria,Falciparum. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A systematic review assessing the role, appropriateness and benefits of the active case detection strategy, both proactive and reactive, in low malaria transmission settings. A common indication is that more studies should be carried out to optimize the ACD strategy to the local context, or to provide evidence for the adoption of improved methods. One possible improved method is the use of more accurate diagnostic tools, such as the hsRDT proposed in this study, with an increased capacity to detect lower levels of parasitemia. It can provide a timely and relevant contribution for their development of national Standard Operating Procedures for a screening tool in the reactive case detection strategy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.